Navigation Links
Gregory J. Tibbitts Appointed Chief Financial Officer at Accumetrics, Inc.
Date:2/26/2009

SAN DIEGO, Calif., Feb. 26 /PRNewswire/ -- Accumetrics, Inc. announced today that the Company has appointed Gregory J. Tibbitts, CPA to the position of Chief Financial Officer.

"We believe Greg's extensive experience in both private and public companies will help Accumetrics to advance our financial operations and bring continued success to the Company," says Timothy I. Still, Chief Executive Officer at Accumetrics. "His deep knowledge of the capital markets and the medical device arena will be important as we maximize the commercial opportunity for our technology."

Mr. Tibbitts's background includes 19 years of corporate finance and technical accounting experience balanced between public accounting and private industry. He has held positions with both publicly traded and privately-held companies, with expertise in risk management, treasury, financing and financial operations.

Prior to Accumetrics, Mr. Tibbitts served as Chief Financial Officer of CryoCor, a publicly-traded medical device company, prior to its acquisition by Boston Scientific Corporation. Mr. Tibbitts joined CryoCor in mid-2004, and was heavily involved in both its Initial Public Offering in July 2005 and its ultimate acquisition in 2008 by Boston Scientific. Before joining CryoCor, Mr. Tibbitts served as Chief Financial Officer of Elitra Pharmaceuticals, a privately-held biotechnology company, and as a Senior Manager in the audit practice of Ernst & Young LLP.

Mr. Tibbitts received a BBA degree from the University of San Diego, and an MBA from San Diego State University, and serves on the Board of Directors of IDMI Pharmaceuticals, a publicly-traded biotechnology company.

About Accumetrics (www.accumetrics.com)

Accumetrics is committed to advancing medical understanding of platelet response and enhancing quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.

Accumetrics' VerifyNow System is the first rapid and easy to use platform for measuring an individual's response to multiple antiplatelet agents. Addressing every major antiplatelet drug, including FDA-cleared products for aspirin, Plavix(R), ReoPro(R), and Integrilin(R), the VerifyNow System provides a valuable tool to help physicians make informed treatment decisions.

The Accumetrics logo and VerifyNow are registered trademarks of Accumetrics, Inc. ReoPro is a registered trademark of Centocor, Inc. Integrilin is a registered trademark of Millennium Pharmaceuticals. Plavix is a registered trademark of Sanofi-Aventis.

    CONTACT:    Jules Abraham
                Lippert Heilshorn & Associates
                212-838-3777
                jabraham@lhai.com

                Timothy I. Still
                Accumetrics
                press@accumetrics.com


'/>"/>
SOURCE Accumetrics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Dr. Gregory Sawyer, of Los Gatos, Has Been Selected by the American Dental Association for the Evidence-Based Dentistry Champion Conference
2. MDdatacor Names Gregory Buchholz Chief Operating Officer
3. American Hospital Management Company Appoints Gregory Ciottone, MD as Chief Medical Officer
4. Congressman Gregory W. Meeks to Ask for Suspension of CARES Process at the St. Albans Veteran Campus
5. Synthetech Announces Appointment of Dr. Gregory R. Hahn as President and Chief Executive Officer
6. Gregory A. Adams Named Northern California Region President of Kaiser Foundation Health Plan and Hospitals
7. Dr. Gregory Buford and Top Plastic Surgeon Selected as a Keynote Speaker at Spa & Resort Expo LA Convention Center, February 23-25
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brickson Diamond Appointed Board Chair of National Hospice Foundation
10. Valensa Internationals Dr. Rudi E. Moerck Appointed CEO
11. Margaret Laub Appointed to IntelliDOT Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... On June 10-11, 2016, A Forever Recovery, a holistic treatment center for ... Table in Battle Creek, MI, where the rehabilitation facility is located. This annual celebration ... world’s leading providers of cereal and other breakfast foods. Its residents often refer to ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts ... applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention ... health care topics including advance care planning, healthcare costs and patient and family ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced ... feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as a ... has released tools for healthy coping following a traumatic event. , Trauma sufferers tend ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Bay Area ... Network,s Dean Center for Tick Borne Illness ... and Rehabilitation, MIT Hacking Medicine, University of California, ... today announced the five finalists of Lyme ... disease.  More than 100 scientists, clinicians, researchers, entrepreneurs, ...
(Date:6/24/2016)... ANDOVER, Mass. and SAN CLEMENTE, Calif. ... California -based mobile pulmonary function testing company, is now ... portable PFT devices developed by ndd Medical Technologies , Inc. ... PFT testing done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ... CA , can get any needed testing done in the ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
Breaking Medicine Technology: